HMGB1 and ischemic stroke: This study aimed to address critical gaps in knowledge by evaluating serum HMGB1 levels drawn within 24 h of ischemic stroke as a predictor of cognitive impairment determined by validated neuropsychological screening at 3-month follow-up.